Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-025402
Filing Date
2021-06-22
Accepted
2021-06-22 19:21:18
Documents
1
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3986
  Complete submission text file 0000899243-21-025402.txt   5401
Mailing Address 2755 CAMPUS DRIVE, SUITE 240 SAN MATEO CA 94403-2538
Business Address
MOMTAZEE JAMES C (Reporting) CIK: 0001209181 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 211036773

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations